Carbetocin Aguettant

Carbetocin Aguettant is a synthetic oxytocin analog used to manage postpartum hemorrhage. This medication is administered intramuscularly or intravenously to support uterine contraction and reduce bleeding after childbirth.

Carbetocin Aguettant is primarily used to prevent or treat postpartum hemorrhage by promoting uterine contractions. It is administered intramuscularly or intravenously to help manage excessive bleeding after childbirth. This medication is often used in clinical settings to ensure the uterus contracts effectively, reducing the risk of complications.

Carbetocin Aguettant works by mimicking the effects of natural oxytocin, which helps the uterus contract. This can reduce bleeding and support the healing process after delivery. Common effects may include uterine contractions and a decrease in postpartum hemorrhage.

Carbetocin Aguettant should be used under medical supervision. It is important to follow the prescribed administration route, whether intramuscular or intravenous. Patients with a history of sensitivity to oxytocin or similar medications should consult their healthcare provider before use.

Carbetocin Aguettant may interact with other medications that affect uterine contractions or blood pressure. It is advisable to inform your healthcare provider about all medications you are taking, including any supplements, to avoid potential interactions.